TCI Wealth Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-518
Closed -$12.2K 1563
2023
Q1
$12.2K Sell
518
-313
-38% -$8.4K ﹤0.01% 967
2022
Q4
$23.2K Buy
831
+249
+43% +$6.37K ﹤0.01% 626
2022
Q3
$14K Sell
582
-13
-2% -$393 ﹤0.01% 834
2022
Q2
$20K Buy
595
+66
+12% +$2.31K ﹤0.01% 644
2022
Q1
$19K Sell
529
-84
-14% -$2.87K ﹤0.01% 724
2021
Q4
$19K Sell
613
-172
-22% -$5.6K ﹤0.01% 738
2021
Q3
$26K Buy
785
+96
+14% +$3.07K ﹤0.01% 588
2021
Q2
$21K Buy
+689
New +$22.7K ﹤0.01% 606

Other funds holding OGN

TCI Wealth Advisors's OGN Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 518 shares — an estimated $12.2K sold.

TCI Wealth Advisors first reported a position in OGN in Q2 2021 and held it in 8 quarters. The position peaked at $26K in Q3 2021. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 518 Organon & Co shares in Q2 2023, an estimated $12.2K.
  • TCI Wealth Advisors first reported a position in Organon & Co in Q2 2021 and held it in 8 quarters.
  • TCI Wealth Advisors's Organon & Co position peaked at $26K in Q3 2021.
  • 726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.